{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:37:43Z","timestamp":1768275463626,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.lfs.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T02:15:21Z","timestamp":1481595321000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker"],"prefix":"10.1016","volume":"173","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.12.007_bb0005","article-title":"Epidemiology of epithelial ovarian cancer","author":"Webb","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.lfs.2016.12.007_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.10.014","article-title":"Precision targeted therapy of ovarian cancer","author":"Sapiezynski","year":"2016","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.lfs.2016.12.007_bb0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.2016.273","article-title":"Ovarian carcinoma diagnosis: the clinical impact of 15years of change","volume":"115","author":"Kommoss","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.lfs.2016.12.007_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jgo.2016.07.008","article-title":"Ovarian cancer in the older woman","volume":"7","author":"Tew","year":"2016","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.lfs.2016.12.007_bb0025","first-page":"151","article-title":"Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management","volume":"8","author":"Beavis","year":"2016","journal-title":"Int. J. Womens Health."},{"issue":"10","key":"10.1016\/j.lfs.2016.12.007_bb0030","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00204-016-1815-7","article-title":"MicroRNA epigenetic signatures in human disease","volume":"90","author":"Pileti\u010d","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"11","key":"10.1016\/j.lfs.2016.12.007_bb0035","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.cellsig.2016.08.011","article-title":"Exploring the cell signalling in hepatocyte differentiation","volume":"28","author":"Vasconcellos","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2016.12.007_bb0040","article-title":"Emerging roles and context of circular RNAs","author":"Panda","year":"2016","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.lfs.2016.12.007_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-016-1828-2","article-title":"Recent progress toward the use of circulating microRNAs as clinical biomarkers","author":"Ghai","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.lfs.2016.12.007_bb0050","first-page":"841","article-title":"MIR376 family and cancer","volume":"31","author":"Tekirdag","year":"2016","journal-title":"Histol. Histopathol."},{"issue":"7","key":"10.1016\/j.lfs.2016.12.007_bb0055","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/ijc.27799","article-title":"Circulating microRNAs in plasma as early detection markers for breast cancer","volume":"132","author":"Cuk","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2016.12.007_bb0060","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1158\/1078-0432.CCR-13-3348","article-title":"A microRNA cluster at 14q32 drives aggressive lung adenocarcinoma","volume":"20","author":"Nadal","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2016.12.007_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076729","article-title":"Plasma microRNA panel for minimally invasive detection of breast cancer","volume":"8","author":"Cuk","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2016.12.007_bb0070","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ijc.22394","article-title":"Expression profiling identifies microRNA signature in pancreatic cancer","volume":"120","author":"Lee","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"34","key":"10.1016\/j.lfs.2016.12.007_bb0075","doi-asserted-by":"crossref","first-page":"54733","DOI":"10.18632\/oncotarget.10752","article-title":"MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2016.12.007_bb0080","doi-asserted-by":"crossref","unstructured":"A Formosa, E K Markert, A M Lena, D Italiano, E Finazzi-Agro, A J Levine, S Bernardini, A V Garabadgiu, G Melino and E Candi, MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells, Oncogene 33, 5173\u20135182.","DOI":"10.1038\/onc.2013.451"},{"key":"10.1016\/j.lfs.2016.12.007_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-11-44","article-title":"Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects ofmir-376a and mir-376c on insulin growth factor 1 receptor","volume":"11","author":"Zehavi","year":"2012","journal-title":"Mol. Cancer"},{"issue":"18","key":"10.1016\/j.lfs.2016.12.007_bb0090","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1158\/1078-0432.CCR-16-1391","article-title":"EPIC early detection of ovarian cancer","volume":"22","author":"Skates","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2016.12.007_bb0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","article-title":"Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma","volume":"186","author":"Bhattacharya","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2016.12.007_bb0100","doi-asserted-by":"crossref","first-page":"15913","DOI":"10.4238\/2015.December.7.2","article-title":"Serum miR-200c expression level as a prognostic biomarker for gastric cancer","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"6","key":"10.1016\/j.lfs.2016.12.007_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5582\/bst.2015.01170","article-title":"Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients","volume":"9","author":"Conev","year":"2016","journal-title":"Bioscience Trends."},{"issue":"12","key":"10.1016\/j.lfs.2016.12.007_bb0110","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1007\/s13277-015-3604-y","article-title":"High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2016.12.007_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2016.00271","article-title":"miR-200c regulation of metastases in ovarian cancer: potential role in epithelial and mesenchymal transition","volume":"7","author":"Sulaiman","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2016.12.007_bb0120","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/cr.2011.79","article-title":"Regulation of erythroid differentiation by miR-376a and its targets","volume":"21","author":"Wang","year":"2011","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.lfs.2016.12.007_bb0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tcm.2014.11.006","article-title":"Kruppel-like factors in muscle health and disease","volume":"25","author":"Prosdocimo","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"issue":"5\u20136","key":"10.1016\/j.lfs.2016.12.007_bb0130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1159\/000178518","article-title":"Kruppel-like factor-15 inhibits the proliferation of mesangial cells","volume":"29","author":"Hong","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2016.12.007_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13402-015-0226-8","article-title":"KLF15 in breast cancer: a novel tumor suppressor?","volume":"38","author":"Yoda","year":"2015","journal-title":"Cell Oncol. (Dordr)."},{"key":"10.1016\/j.lfs.2016.12.007_bb0140","first-page":"7(12)","article-title":"Cell death signaling","volume":"1","author":"Green","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2016.12.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087925","article-title":"CASP8-652 6 N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2016.12.007_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.onc.1208244","article-title":"Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225-1226delTG inhepatocellular carcinomas","volume":"24","author":"Soung","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.lfs.2016.12.007_bb0155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/0008-5472.815.65.3","article-title":"CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas","volume":"65","author":"Soung","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2016.12.007_bb0160","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1566524014666140128111951","article-title":"Caspase-8 as a regulator of tumor cell motility","volume":"14","author":"Graf","year":"2014","journal-title":"Curr. Mol. Med."},{"issue":"12","key":"10.1016\/j.lfs.2016.12.007_bb0165","first-page":"2526","article-title":"Evidence for miR-17-92 and miR-134 gene cluster regulation of ovarian cancer drug resistance","volume":"20","author":"Zhu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:25:20Z","timestamp":1658017520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516306920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"alternative-id":["S0024320516306920"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.12.007","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}